Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
J Am Med Inform Assoc. 2010 Nov-Dec;17(6):631-6. doi: 10.1136/jamia.2009.000794.
Medication errors are a major source of morbidity and mortality. Inadequate laboratory monitoring of high-risk medications after initial prescription is a medical error that contributes to preventable adverse drug events. Health information technology (HIT)-based clinical decision support may improve patient safety by improving the laboratory monitoring of high-risk medications, but the effectiveness of such interventions is unclear. Therefore, the authors conducted a systematic review to identify studies that evaluate the independent effect of HIT interventions on improving laboratory monitoring for high-risk medications in the ambulatory setting using a Medline search from January 1, 1980 through January 1, 2009 and a manual review of relevant bibliographies. All anticoagulation monitoring studies were excluded. Eight articles met the inclusion criteria, including six randomized controlled trials and two pre-post intervention studies. Six of the studies were conducted in two large, integrated healthcare delivery systems in the USA. Overall, five of the eight studies reported statistically significant, but small, improvements in laboratory monitoring; only half of the randomized controlled trials reported statistically significant improvements. Studies that found no improvement were more likely to have used analytic strategies that addressed clustering and confounding. Whether HIT improves laboratory monitoring of certain high-risk medications for ambulatory patients remains unclear, and further research is needed to clarify this important question.
用药错误是发病率和死亡率的主要原因。初始处方后对高危药物进行不充分的实验室监测是一种医疗错误,可导致可预防的药物不良事件。基于健康信息技术(HIT)的临床决策支持系统可以通过改善高危药物的实验室监测来提高患者安全性,但此类干预措施的效果尚不清楚。因此,作者进行了系统评价,以确定使用 Medline 从 1980 年 1 月 1 日至 2009 年 1 月 1 日进行的搜索以及对相关参考文献的手动审查来识别评估 HIT 干预措施对改善门诊高危药物实验室监测效果的独立影响的研究。所有抗凝监测研究均被排除。符合纳入标准的有 8 篇文章,包括 6 项随机对照试验和 2 项前后干预研究。其中 6 项研究在美国两个大型综合性医疗服务系统中进行。总的来说,8 篇研究中有 5 篇报道了实验室监测的统计学显著但较小的改善;只有一半的随机对照试验报道了统计学上的显著改善。未发现改善的研究更可能使用了处理聚类和混杂的分析策略。HIT 是否改善了门诊患者某些高危药物的实验室监测仍不清楚,需要进一步研究来阐明这一重要问题。